KDM6B (Lysine-specific demethylase 6B) variants and mutations
KDM6B (also known as Lysine-specific demethylase 6B) is a human protein-coding gene encoding a lysine-specific demethylase 6B protein. It removes repressive H3K27 methylation and helps activate developmental, inflammatory, and differentiation programs. Heterozygous pathogenic variants can cause a neurodevelopmental disorder with intellectual disability and variable craniofacial or skeletal features. This analysis covers 2,502 KDM6B variants and mutations. Of these, 73% have computational variant effect predictions. Disease context includes neurodevelopmental disorder with coarse facies and mild distal skeletal abnormal, hereditary disease, and syndromic intellectual disability. Example KDM6B variants include H2R, H2Y, and R3Q.
Variant analysis overview
- Gene: KDM6B
- Protein: Lysine-specific demethylase 6B
- UniProt accession: O15054
- Organism: Homo sapiens
- Variants analyzed: 2502
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 2,334 unspecified-consequence records; 83 synonymous variants; 70 missense variants; 1 stop-gained variants; 5 in-frame deletions; 1 in-frame insertions; 4 splice-region variants; 1 frameshift variants; 3 substitution
- Prediction scores: 1,816 variants have prediction scores (73% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: neurodevelopmental disorder with coarse facies and mild distal skeletal abnormal, hereditary disease, syndromic intellectual disability, autosomal recessive non-syndromic intellectual disability, Neurodevelopmental abnormality, Neurodevelopmental delay, Intellectual disability, autism spectrum disorder, Abnormality of the skeletal system, arthropathy, developmental disability, musculoskeletal system disorder.
Protein structure and variant hotspots
- Protein features: 1 domains; 7 binding sites; 1 post-translational modification sites.
- Structural context: 144 variants have structural context.
- PTM context: 1 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable KDM6B variants
Examples include H2R, H2Y, R3Q, R3W, R3R, A4E, A4S, A4V. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- H2R (p.His2Arg), rs1318862422, ClinGen CA397909808, ClinVar RCV004409185, TOPMed rs1318862422, REVEL 0.33, MetaLR 0.14, Uncertain significance, Inborn genetic diseases
- H2Y (p.His2Tyr), ExAC rs766277946, TOPMed rs766277946, gnomAD rs766277946, REVEL 0.15, MetaLR 0.06
- R3Q (p.Arg3Gln), cosmic curated COSV10583, ExAC rs752757203, gnomAD rs752757203, REVEL 0.18, MetaLR 0.10
- R3W (p.Arg3Trp), cosmic curated COSV10729, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R3R (p.Arg3Arg), gnomAD 17-7845563-G-C, CADD 12.40
- A4E (p.Ala4Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A4S (p.Ala4Ser), TOPMed rs2078514402
- A4V (p.Ala4Val), gnomAD 17-7845565-C-T, REVEL 0.14, CADD 28.10
- A4A (p.Ala4Ala), gnomAD 17-7845566-A-G, CADD 14.80
- V5L (p.Val5Leu), ESP rs149672098, ExAC rs149672098, TOPMed rs149672098, gnomAD rs149672098, REVEL 0.08, MetaLR 0.09
- D6E (p.Asp6Glu), ExAC rs777910831, TOPMed rs777910831, gnomAD rs777910831, REVEL 0.04, MetaLR 0.04
- D6G (p.Asp6Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D6D (p.Asp6Asp), rs777910831, gnomAD 17-7845572-C-T, CADD 11.70
- P7L (p.Pro7Leu), NCI-TCGA Cosmic COSV9964, cosmic curated COSV99642, Ensembl rs2078514615, REVEL 0.14, MetaLR 0.04, Uncertain significance, Inborn genetic diseases
- P8T (p.Pro8Thr), Ensembl rs2151375278
- P8S (p.Pro8Ser), gnomAD 17-7845576-C-T, REVEL 0.04, CADD 22.70
- G9A (p.Gly9Ala), Ensembl rs1225126943, REVEL 0.27, MetaLR 0.18
- G9G (p.Gly9Gly), rs545200585, gnomAD 17-7845581-G-C, CADD 12.50
- A10S (p.Ala10Ser), cosmic curated COSV99642, MetaLR 0.07, MetaSVM -1.02
- A10T (p.Ala10Thr), TOPMed rs1338580025, gnomAD rs1338580025, REVEL 0.12, MetaLR 0.07
- A10V (p.Ala10Val), ESP rs145441642, TOPMed rs145441642, gnomAD rs145441642, REVEL 0.10, MetaLR 0.07
- R11C (p.Arg11Cys), ExAC rs757487883, gnomAD rs757487883, REVEL 0.09, MetaLR 0.09
- R11H (p.Arg11His), cosmic curated COSV54681, ExAC rs779450351, TOPMed rs779450351, gnomAD rs779450351, REVEL 0.15, MetaLR 0.16
- R11L (p.Arg11Leu), cosmic curated COSV54684, ExAC rs779450351, TOPMed rs779450351, gnomAD rs779450351, REVEL 0.20, MetaLR 0.15
- R11P (p.Arg11Pro), ExAC rs779450351, TOPMed rs779450351, gnomAD rs779450351, REVEL 0.19, MetaLR 0.16
- R11S (p.Arg11Ser), ExAC rs757487883, gnomAD rs757487883, REVEL 0.17, MetaLR 0.15
- R11G (p.Arg11Gly), gnomAD 17-7845585-C-G, REVEL 0.18, CADD 26.10
- R11R (p.Arg11Arg), gnomAD 17-7845587-C-A, CADD 13.20
- A12G (p.Ala12Gly), gnomAD rs1269560563, REVEL 0.09, MetaLR 0.06
- A12T (p.Ala12Thr), TOPMed rs2078515068
- A13S (p.Ala13Ser), rs373339030, ClinGen CA8360031, ClinVar RCV003044890, 1000Genomes rs373339030, REVEL 0.07, MetaLR 0.03, Uncertain significance, not provided
- A13T (p.Ala13Thr), 1000Genomes rs373339030, ESP rs373339030, ExAC rs373339030, gnomAD rs373339030, REVEL 0.04, MetaLR 0.03, Uncertain significance
- A13V (p.Ala13Val), ExAC rs746560165, gnomAD rs746560165, REVEL 0.06, MetaLR 0.07
- A13A (p.Ala13Ala), gnomAD 17-7845593-A-T, CADD 14.20
- R14Q (p.Arg14Gln), rs527933230, ClinGen CA8360034, ClinVar RCV003944488, ClinVar RCV005363318, REVEL 0.18, MetaLR 0.16, Uncertain significance, Inborn genetic diseases
- R14W (p.Arg14Trp), rs1253485830, NCI-TCGA Cosmic COSV5468, cosmic curated COSV54683, gnomAD rs1253485830, Variant assessed as somatic; moderate impact.
- R14L (p.Arg14Leu), gnomAD 17-7845595-G-T, REVEL 0.28, CADD 29.70
- E15* (p.Glu15Ter), gnomAD 17-7845597-G-T, CADD 41.00
- A16V (p.Ala16Val), cosmic curated COSV10807, REVEL 0.08, MetaLR 0.05
- A16S (p.Ala16Ser), gnomAD 17-7845600-G-T, REVEL 0.03, CADD 18.90
- A16A (p.Ala16Ala), rs2078515451, gnomAD 17-7845602-C-G, CADD 13.60
- F17C (p.Phe17Cys), gnomAD 17-7845604-T-G, REVEL 0.30, CADD 29.60
- A18A (p.Ala18Ala), gnomAD 17-7845608-C-G, CADD 13.50
- L19F (p.Leu19Phe), rs775940947, ClinGen CA8360035, ClinVar RCV003405931, ClinVar RCV005932773, REVEL 0.16, MetaLR 0.09, Uncertain significance, not specified
- L19P (p.Leu19Pro), ExAC rs761487599, TOPMed rs761487599, gnomAD rs761487599, REVEL 0.26, MetaLR 0.05
- G20E (p.Gly20Glu), TOPMed rs1252771491, gnomAD rs1252771491, REVEL 0.16, MetaLR 0.04, Uncertain significance, not specified
- G20V (p.Gly20Val), cosmic curated COSV99641
- G21A (p.Gly21Ala), ExAC rs764823980, TOPMed rs764823980, gnomAD rs764823980, REVEL 0.13, MetaLR 0.07, Uncertain significance
- G21D (p.Gly21Asp), rs764823980, ClinGen CA397910078, ClinVar RCV003885985, ExAC rs764823980, REVEL 0.17, MetaLR 0.10, Uncertain significance, not provided
- G21del (p.Gly21del), gnomAD 17-7845611-TGGG-T, CADD 20.90
- G21G (p.Gly21Gly), rs549560063, gnomAD 17-7845617-C-G, CADD 13.60
- L22Q (p.Leu22Gln), gnomAD rs1454523439, REVEL 0.25, MetaLR 0.16
- L22V (p.Leu22Val), gnomAD rs1347146144, REVEL 0.22, MetaLR 0.11
- L22M (p.Leu22Met), gnomAD 17-7845618-C-A, REVEL 0.22, CADD 23.80
- S23N (p.Ser23Asn), gnomAD 17-7845622-G-A, REVEL 0.04, CADD 23.50
- S23S (p.Ser23Ser), gnomAD 17-7845623-C-T, CADD 13.90
- C24Y (p.Cys24Tyr), gnomAD rs1302314690, REVEL 0.18, MetaLR 0.08
- C24R (p.Cys24Arg), gnomAD 17-7845624-T-C, REVEL 0.22, CADD 22.80
- C24C (p.Cys24Cys), gnomAD 17-7845626-T-C, CADD 14.00
- A25V (p.Ala25Val), rs766290398, NCI-TCGA Cosmic COSV5467, cosmic curated COSV54677, ExAC rs766290398, REVEL 0.06, MetaLR 0.05, Variant assessed as somatic; moderate impact.
- A25S (p.Ala25Ser), gnomAD 17-7845627-G-T, REVEL 0.04, CADD 19.60
- A25G (p.Ala25Gly), gnomAD 17-7845628-C-G, REVEL 0.06, CADD 22.80
- A25A (p.Ala25Ala), gnomAD 17-7845629-T-C, CADD 14.80
- G26R (p.Gly26Arg), gnomAD rs1400214515, REVEL 0.19, MetaLR 0.10
- G26V (p.Gly26Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G26W (p.Gly26Trp), gnomAD 17-7845630-G-T, REVEL 0.21, CADD 29.50
- G26G (p.Gly26Gly), gnomAD 17-7845632-G-A, CADD 12.60
- A27V (p.Ala27Val), ExAC rs751498485, TOPMed rs751498485, gnomAD rs751498485, REVEL 0.06, MetaLR 0.05, Uncertain significance, Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormal
- A27S (p.Ala27Ser), gnomAD 17-7845633-G-T, REVEL 0.04, CADD 23.30
- W28C (p.Trp28Cys), cosmic curated COSV54686
- W28G (p.Trp28Gly), Ensembl rs879080415
- W28R (p.Trp28Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S29N (p.Ser29Asn), ExAC rs754814272, gnomAD rs754814272, REVEL 0.05, MetaLR 0.04
- S29R (p.Ser29Arg), TOPMed rs2078516361
- S30C (p.Ser30Cys), TOPMed rs1438275302, gnomAD rs1438275302, REVEL 0.16, MetaLR 0.20
- S30F (p.Ser30Phe), cosmic curated COSV10729
- S30P (p.Ser30Pro), NCI-TCGA Cosmic COSV9964, cosmic curated COSV99642, REVEL 0.23, MetaLR 0.10, Variant assessed as somatic; moderate impact.
- S30A (p.Ser30Ala), gnomAD 17-7845642-T-G, REVEL 0.16, CADD 23.90
- S30S (p.Ser30Ser), rs2078516475, gnomAD 17-7845644-C-T, CADD 13.70
- C31Y (p.Cys31Tyr), ExAC rs764238434, TOPMed rs764238434, gnomAD rs764238434, REVEL 0.19, MetaLR 0.08
- C31C (p.Cys31Cys), gnomAD 17-7845647-C-T, CADD 13.10
- P32L (p.Pro32Leu), rs753819960, ClinGen CA8360044, cosmic curated COSV54687, ClinVar RCV001754349, REVEL 0.05, MetaLR 0.05, Uncertain significance, not provided; Neurodevelopmental disorder with coarse facies and mild distal ske
- P32S (p.Pro32Ser), cosmic curated COSV54677, Ensembl rs868289800
- P32T (p.Pro32Thr), gnomAD 17-7845648-C-A, REVEL 0.04, CADD 22.70
- P32Q (p.Pro32Gln), gnomAD 17-7845649-C-A, REVEL 0.04, CADD 23.10
- P32P (p.Pro32Pro), rs757574367, gnomAD 17-7845650-G-A, CADD 11.20
- P33S (p.Pro33Ser), ExAC rs779247041, gnomAD rs779247041, REVEL 0.08, MetaLR 0.12
- P33L (p.Pro33Leu), gnomAD 17-7845652-C-T, REVEL 0.14, CADD 25.70
- P33P (p.Pro33Pro), rs746303332, gnomAD 17-7845653-T-C, CADD 13.80
- H34Y (p.His34Tyr), ESP rs377441486, ExAC rs377441486, TOPMed rs377441486, gnomAD rs377441486, REVEL 0.11, MetaLR 0.05
- P35H (p.Pro35His), TOPMed rs1483985578, gnomAD rs1483985578, REVEL 0.24, MetaLR 0.14
- P35L (p.Pro35Leu), TOPMed rs1483985578, gnomAD rs1483985578, REVEL 0.19, MetaLR 0.14
- P35R (p.Pro35Arg), TOPMed rs1483985578, gnomAD rs1483985578, REVEL 0.20, MetaLR 0.14
- p.Pro35 Pro36insArgSerCysProProH, gnomAD 17-7845639-A-AGCT, CADD 19.70
- P35P (p.Pro35Pro), rs1213628474, gnomAD 17-7845659-C-T, CADD 12.00
- P36L (p.Pro36Leu), NCI-TCGA TCGA novel, Uncertain significance, Inborn genetic diseases
- P36S (p.Pro36Ser), gnomAD rs1258751281, REVEL 0.13, MetaLR 0.09
- P37L (p.Pro37Leu), rs747558929, ClinGen CA8360050, ClinVar RCV003399702, ClinVar RCV004634251, REVEL 0.03, MetaLR 0.06, Uncertain significance, KDM6B-related disorder; Inborn genetic diseases
- P37S (p.Pro37Ser), 1000Genomes rs561573131, ExAC rs561573131, gnomAD rs561573131, REVEL 0.07, MetaLR 0.03, Uncertain significance, Inborn genetic diseases
- R38C (p.Arg38Cys), NCI-TCGA Cosmic COSV5468, cosmic curated COSV54680, Ensembl rs2078517218, REVEL 0.21, MetaLR 0.09, Variant assessed as somatic; moderate impact.
- R38H (p.Arg38His), 1000Genomes rs531880923, ExAC rs531880923, TOPMed rs531880923, gnomAD rs531880923, REVEL 0.22, MetaLR 0.08
- R38L (p.Arg38Leu), cosmic curated COSV54681
- R38P (p.Arg38Pro), 1000Genomes rs531880923, ExAC rs531880923, TOPMed rs531880923, gnomAD rs531880923, REVEL 0.19, MetaLR 0.08
- R38R (p.Arg38Arg), gnomAD 17-7845668-T-A, CADD 9.96
- S39G (p.Ser39Gly), Ensembl rs2078517372
- S39R (p.Ser39Arg), ExAC rs769473886, TOPMed rs769473886, gnomAD rs769473886, REVEL 0.20, MetaLR 0.04
- S39T (p.Ser39Thr), rs544737445, ClinGen CA8360053, ClinVar RCV003240688, 1000Genomes rs544737445, REVEL 0.06, MetaLR 0.04, Likely benign, Inborn genetic diseases
- S39S (p.Ser39Ser), rs769473886, gnomAD 17-7845671-C-T, CADD 11.50
- A40T (p.Ala40Thr), rs866351379, cosmic curated COSV10807, TOPMed rs866351379, REVEL 0.11, MetaLR 0.03, Uncertain significance, Inborn genetic diseases
- W41C (p.Trp41Cys), TOPMed rs2078517616
- L42L (p.Leu42Leu), rs762789402, gnomAD 17-7845678-C-T, CADD 12.30
- P43L (p.Pro43Leu), gnomAD rs1375989663, REVEL 0.19, MetaLR 0.09
- P43S (p.Pro43Ser), TOPMed rs2078517721, gnomAD rs2078517721, REVEL 0.09, MetaLR 0.12
- P43P (p.Pro43Pro), rs2078517831, gnomAD 17-7845683-T-C, CADD 12.80
- G44E (p.Gly44Glu), gnomAD rs1436601341, REVEL 0.21, MetaLR 0.04
- G44R (p.Gly44Arg), gnomAD 17-7845684-G-A, REVEL 0.16, CADD 24.20
- G45S (p.Gly45Ser), TOPMed rs2078517965, REVEL 0.25, MetaLR 0.06
- G45G (p.Gly45Gly), gnomAD 17-7845689-C-A, CADD 17.40
- R46R (p.Arg46Arg), rs763262499, gnomAD 17-7845872-A-G, CADD 15.60
- C47S (p.Cys47Ser), Ensembl rs927219615
- C47C (p.Cys47Cys), gnomAD 17-7845875-C-T, CADD 9.06
- C47W (p.Cys47Trp), gnomAD 17-7845875-C-G, REVEL 0.47, CADD 23.70
- S48L (p.Ser48Leu), gnomAD 17-7845877-C-T, REVEL 0.07, CADD 24.10
- A49S (p.Ala49Ser), Ensembl rs2078522876, REVEL 0.04, MetaLR 0.02
- A49A (p.Ala49Ala), gnomAD 17-7845881-C-T, CADD 12.40
- S50G (p.Ser50Gly), gnomAD 17-7845882-A-G, REVEL 0.02, CADD 23.30
- S50S (p.Ser50Ser), rs372282783, gnomAD 17-7845884-C-T, CADD 10.80
- I51M (p.Ile51Met), Ensembl rs1597833679
- I51T (p.Ile51Thr), ExAC rs755289949, gnomAD rs755289949, REVEL 0.04, MetaLR 0.07
- I51V (p.Ile51Val), ExAC rs751998041, gnomAD rs751998041, REVEL 0.06, MetaLR 0.05
- I51I (p.Ile51Ile), gnomAD 17-7845887-T-C, CADD 4.84
- G52G (p.Gly52Gly), rs781704985, gnomAD 17-7845890-G-A, CADD 9.48
- Q53* (p.Gln53Ter), cosmic curated COSV99640
- Q53K (p.Gln53Lys), Ensembl rs1819889539
- P54H (p.Pro54His), rs756544042, NCI-TCGA Cosmic COSV5468, cosmic curated COSV54687, ExAC rs756544042, REVEL 0.04, MetaLR 0.05, Variant assessed as somatic; moderate impact.
- P54S (p.Pro54Ser), rs202081763, ClinGen CA8360090, ClinVar RCV002682369, 1000Genomes rs202081763, REVEL 0.02, MetaLR 0.04, Uncertain significance, Inborn genetic diseases
- P54P (p.Pro54Pro), rs777295095, gnomAD 17-7845896-C-T, CADD 9.38
- P55L (p.Pro55Leu), TOPMed rs1490712554, gnomAD rs1490712554, REVEL 0.04, MetaLR 0.03
- P55R (p.Pro55Arg), rs1490712554, ClinGen CA397910556, ClinVar RCV004409170, NCI-TCGA TCGA novel, REVEL 0.05, MetaLR 0.03, Uncertain significance, Inborn genetic diseases
- P55S (p.Pro55Ser), TOPMed rs2078523375, Uncertain significance, Inborn genetic diseases
- P55P (p.Pro55Pro), rs148819146, gnomAD 17-7845899-G-T, CADD 0.44
- L56F (p.Leu56Phe), gnomAD 17-7845900-C-T, REVEL 0.10, CADD 23.60
- P57L (p.Pro57Leu), ESP rs373734474, ExAC rs373734474, TOPMed rs373734474, gnomAD rs373734474, REVEL 0.05, MetaLR 0.06
- P57S (p.Pro57Ser), gnomAD 17-7845903-C-T, REVEL 0.07, CADD 9.50
- P57A (p.Pro57Ala), gnomAD 17-7845903-C-G, REVEL 0.11, CADD 13.60
- A58D (p.Ala58Asp), NCI-TCGA Cosmic COSV9964, cosmic curated COSV99641, Variant assessed as somatic; moderate impact.
- A58G (p.Ala58Gly), 1000Genomes rs200483669, ExAC rs200483669, TOPMed rs200483669, gnomAD rs200483669, REVEL 0.10, MetaLR 0.09
- P59A (p.Pro59Ala), TOPMed rs1214538742, gnomAD rs1214538742, REVEL 0.04, MetaLR 0.04
- P59L (p.Pro59Leu), Ensembl rs1567788701, REVEL 0.04, MetaLR 0.04
- P59S (p.Pro59Ser), rs1214538742, TOPMed rs1214538742, gnomAD rs1214538742, REVEL 0.04, MetaLR 0.03, Variant assessed as somatic; moderate impact.
- P59T (p.Pro59Thr), gnomAD 17-7845909-C-A, REVEL 0.05, CADD 17.30
- P59P (p.Pro59Pro), rs1267677891, gnomAD 17-7845911-C-T, CADD 8.32
- L60L (p.Leu60Leu), rs1445500706, gnomAD 17-7845912-C-T, CADD 5.96
- L60Q (p.Leu60Gln), gnomAD 17-7845913-T-A, REVEL 0.13, CADD 24.70
- P61L (p.Pro61Leu), rs1472409768, ClinGen CA397910588, ClinVar RCV003236095, Uncertain significance, not provided
- P61R (p.Pro61Arg), gnomAD rs1472409768, REVEL 0.23, MetaLR 0.10
- P61S (p.Pro61Ser), cosmic curated COSV54684, ESP rs372387925, ExAC rs372387925, gnomAD rs372387925
- P61P (p.Pro61Pro), rs1597833828, gnomAD 17-7845917-C-T, CADD 9.12
- P62A (p.Pro62Ala), rs144535196, ClinGen CA8360099, ClinVar RCV002840605, ESP rs144535196, REVEL 0.10, MetaLR 0.04, Uncertain significance, Inborn genetic diseases
- P62H (p.Pro62His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P62L (p.Pro62Leu), ExAC rs768670113, gnomAD rs768670113, REVEL 0.13, MetaLR 0.08
- P62S (p.Pro62Ser), rs144535196, ClinGen CA8360098, ClinVar RCV004409172, ESP rs144535196, REVEL 0.09, MetaLR 0.03, Likely benign, Inborn genetic diseases
- P62T (p.Pro62Thr), rs144535196, ClinGen CA397910590, ClinVar RCV003227258, REVEL 0.17, MetaLR 0.06, Uncertain significance, not provided
- S63L (p.Ser63Leu), NCI-TCGA TCGA novel, REVEL 0.09, MetaLR 0.03, Variant assessed as somatic; moderate impact.
- H64R (p.His64Arg), cosmic curated COSV10503, REVEL 0.16, MetaLR 0.10
- H64Y (p.His64Tyr), gnomAD 17-7845924-C-T, REVEL 0.14, CADD 24.30
- G65D (p.Gly65Asp), TOPMed rs1358599972, gnomAD rs1358599972, REVEL 0.18, MetaLR 0.06, Uncertain significance, Inborn genetic diseases
- G65G (p.Gly65Gly), gnomAD 17-7845929-C-T, CADD 13.30
- S66N (p.Ser66Asn), ExAC rs773477615, TOPMed rs773477615, gnomAD rs773477615, REVEL 0.07, MetaLR 0.03, Uncertain significance, Inborn genetic diseases
- S67N (p.Ser67Asn), ExAC rs766687897, gnomAD rs766687897, REVEL 0.04, MetaLR 0.03
- S67R (p.Ser67Arg), ExAC rs774420605, TOPMed rs774420605, gnomAD rs774420605, REVEL 0.10, MetaLR 0.04
- S67S (p.Ser67Ser), rs774420605, gnomAD 17-7845935-T-C, CADD 9.64
- S68F (p.Ser68Phe), TOPMed rs1318377325, gnomAD rs1318377325, REVEL 0.06, MetaLR 0.03
- S68C (p.Ser68Cys), gnomAD 17-7845937-C-G, REVEL 0.08, CADD 24.70
- G69A (p.Gly69Ala), ESP rs375162097, TOPMed rs375162097, gnomAD rs375162097
- G69E (p.Gly69Glu), ESP rs375162097, TOPMed rs375162097, gnomAD rs375162097, REVEL 0.17, MetaLR 0.11
- G69G (p.Gly69Gly), rs759742385, gnomAD 17-7845941-G-A, CADD 7.91
- H70P (p.His70Pro), ExAC rs753019722, TOPMed rs753019722, gnomAD rs753019722, REVEL 0.18, MetaLR 0.08, Uncertain significance, Inborn genetic diseases
- H70Y (p.His70Tyr), ExAC rs767869008, TOPMed rs767869008, gnomAD rs767869008, REVEL 0.07, MetaLR 0.04
- H70H (p.His70His), gnomAD 17-7845944-C-T, CADD 6.95
Public KDM6B analysis runs
- KDM6B analysis run — KDM6B (2,502 variants) — completed 2026-08-20